Health2023 saw a cautious hope for Alzheimer's treatment but doubts remain The US approved lecanemab to slow cognitive decline among people with early Alzheimer's, but not everyone is convinced the drug has that big of an impact – not to mention concerns over its safety and practicality News
Technology2023 was the year that artificial intelligence went mainstream From ChatGPT to Gemini, this year was dominated by large language models and other AIs becoming everyday tools used by millions of people News